BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 36080457)

  • 21. Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer.
    Yang XH; Li KG; Wei JB; Wu CH; Liang SX; Mo XW; Chen JS; Tang WZ; Qu S
    Sci Rep; 2020 Jul; 10(1):12539. PubMed ID: 32719436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, Characterization and
    Patel P; Barot T; Kulkarni P
    Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of Polymeric Microparticles by Electrospray: The Impact of Experimental Parameters.
    Morais AÍS; Vieira EG; Afewerki S; Sousa RB; Honorio LMC; Cambrussi ANCO; Santos JA; Bezerra RDS; Furtini JAO; Silva-Filho EC; Webster TJ; Lobo AO
    J Funct Biomater; 2020 Jan; 11(1):. PubMed ID: 31952157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-loaded polysaccharides-based complex particles obtained by polyelectrolyte complexation and ionic gelation. I-Particles obtaining and characterization.
    Iurciuc-Tincu CE; Atanase LI; Ochiuz L; Jérôme C; Sol V; Martin P; Popa M
    Int J Biol Macromol; 2020 Mar; 147():629-642. PubMed ID: 31904456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer.
    Dekker E; Tanis PJ; Vleugels JLA; Kasi PM; Wallace MB
    Lancet; 2019 Oct; 394(10207):1467-1480. PubMed ID: 31631858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targets for improving tumor response to radiotherapy.
    Mortezaee K; Parwaie W; Motevaseli E; Mirtavoos-Mahyari H; Musa AE; Shabeeb D; Esmaely F; Najafi M; Farhood B
    Int Immunopharmacol; 2019 Nov; 76():105847. PubMed ID: 31466051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling.
    Jin P; Jiang J; Xie N; Zhou L; Huang Z; Zhang L; Qin S; Fu S; Peng L; Gao W; Li B; Lei Y; Nice EC; Li C; Shao J; Xie K
    Cell Death Dis; 2019 Aug; 10(8):615. PubMed ID: 31409796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coaxial Electrohydrodynamic Atomization for the Production of Drug-Loaded Micro/Nanoparticles.
    Chen C; Liu W; Jiang P; Hong T
    Micromachines (Basel); 2019 Feb; 10(2):. PubMed ID: 30769856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrospraying an enabling technology for pharmaceutical and biomedical applications: A review.
    Boda SK; Li X; Xie J
    J Aerosol Sci; 2018 Nov; 125():164-181. PubMed ID: 30662086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy with melatonin for targeting human cancers: A review.
    Najafi M; Salehi E; Farhood B; Nashtaei MS; Hashemi Goradel N; Khanlarkhani N; Namjoo Z; Mortezaee K
    J Cell Physiol; 2019 Mar; 234(3):2356-2372. PubMed ID: 30192001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.
    Yu DG; Li JJ; Williams GR; Zhao M
    J Control Release; 2018 Dec; 292():91-110. PubMed ID: 30118788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.
    Dudhipala N; Puchchakayala G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1572-1582. PubMed ID: 29493289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives.
    Banerjee A; Pathak S; Subramanium VD; G D; Murugesan R; Verma RS
    Drug Discov Today; 2017 Aug; 22(8):1224-1232. PubMed ID: 28545838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation.
    Gad HA; Kamel AO; Ezzat OM; El Dessouky HF; Sammour OA
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1241-1251. PubMed ID: 28485988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osimertinib effective in EGFR T790M-positive lung cancer.
    Mayor S
    Lancet Oncol; 2017 Jan; 18(1):e9. PubMed ID: 27989430
    [No Abstract]   [Full Text] [Related]  

  • 36. Par3L enhances colorectal cancer cell survival by inhibiting Lkb1/AMPK signaling pathway.
    Li T; Liu D; Lei X; Jiang Q
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1037-1041. PubMed ID: 27908725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of pharmacogenetics in capecitabine efficacy and toxicity.
    Lam SW; Guchelaar HJ; Boven E
    Cancer Treat Rev; 2016 Nov; 50():9-22. PubMed ID: 27569869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo.
    Chen Z; Chen Y; Xu M; Chen L; Zhang X; To KK; Zhao H; Wang F; Xia Z; Chen X; Fu L
    Mol Cancer Ther; 2016 Aug; 15(8):1845-58. PubMed ID: 27196753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.
    Zhang N; Fu JN; Chou TC
    Am J Cancer Res; 2016; 6(1):97-104. PubMed ID: 27073727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
    Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
    World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.